MA53158A - Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès - Google Patents
Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpèsInfo
- Publication number
- MA53158A MA53158A MA053158A MA53158A MA53158A MA 53158 A MA53158 A MA 53158A MA 053158 A MA053158 A MA 053158A MA 53158 A MA53158 A MA 53158A MA 53158 A MA53158 A MA 53158A
- Authority
- MA
- Morocco
- Prior art keywords
- modulating
- screening
- methods
- herpes virus
- identifying agents
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 241001529453 unidentified herpesvirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/03—Herpetoviridae, e.g. pseudorabies virus
- C07K14/04—Varicella-zoster virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/03—Herpetoviridae, e.g. pseudorabies virus
- C07K14/05—Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/04—Varicella-zoster virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/05—Epstein-Barr virus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18184806 | 2018-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53158A true MA53158A (fr) | 2021-05-26 |
Family
ID=63014438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053158A MA53158A (fr) | 2018-07-20 | 2019-07-19 | Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12276665B2 (fr) |
| EP (1) | EP3823979B8 (fr) |
| AU (2) | AU2019304526B2 (fr) |
| CA (1) | CA3106833A1 (fr) |
| ES (1) | ES3005559T3 (fr) |
| MA (1) | MA53158A (fr) |
| WO (1) | WO2020016433A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7802256B2 (ja) | 2020-08-05 | 2026-01-20 | サニオナ アクティーゼルスカブ | ジフルオロメチル－ピリジン－２－イルトリアゾール |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| ES2087997T3 (es) | 1990-01-12 | 1996-08-01 | Cell Genesys Inc | Generacion de anticuerpos xenogenicos. |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| JPH06508511A (ja) | 1990-07-10 | 1994-09-29 | ケンブリッジ アンティボディー テクノロジー リミティド | 特異的な結合ペアーの構成員の製造方法 |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5770358A (en) | 1991-09-18 | 1998-06-23 | Affymax Technologies N.V. | Tagged synthetic oligomer libraries |
| EP0746609A4 (fr) | 1991-12-17 | 1997-12-17 | Genpharm Int | Animaux transgeniques non humains capables de produire des anticorps heterologues |
| DE69333087T2 (de) | 1992-10-01 | 2004-05-06 | The Trustees Of Columbia University In The City Of New York | Komplexe kombinatorische chemische banken, die mit markierungen versehen sind |
| NZ276860A (en) | 1993-11-02 | 1997-09-22 | Affymax Tech Nv | Apparatus and its use for synthesising diverse molecular products on substrates |
| CA2189634A1 (fr) | 1994-05-06 | 1995-11-16 | John J. Baldwin | Bibliotheque combinatoire de dihydrobenzopyranes |
| US5663046A (en) | 1994-06-22 | 1997-09-02 | Pharmacopeia, Inc. | Synthesis of combinatorial libraries |
| EP1135498B1 (fr) * | 1998-11-18 | 2008-01-23 | Genentech, Inc. | Variants d'anticorps a affinite de liaison superieure par rapport aux anticorps d'origine |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| CA2645507A1 (fr) * | 2006-03-10 | 2007-09-20 | The Regents Of The University Of California | Vaccins pour des virus provoquant des infections persistantes ou latentes |
| NZ600974A (en) * | 2009-12-23 | 2014-08-29 | 4Antibody Ag | Binding members for human cytomegalovirus |
| CA3128572C (fr) * | 2010-05-05 | 2023-02-21 | Christian Thirion | Vaccin contre une infection a virus herpes beta et utilisation correspondante |
| CA2890061A1 (fr) * | 2012-12-04 | 2014-06-12 | Merck Sharp & Dohme Corp. | Vecteurs viraux a replication conditionnelle |
| US20150051090A1 (en) * | 2013-08-19 | 2015-02-19 | D.E. Shaw Research, Llc | Methods for in silico screening |
| WO2017157969A1 (fr) * | 2016-03-14 | 2017-09-21 | Redbiotec Ag | Moyens et méthodes pour le traitement du vhs |
| JP7614842B2 (ja) * | 2018-04-03 | 2025-01-16 | サノフイ | 抗原性エプスタインバーウイルスポリペプチド |
-
2019
- 2019-07-19 MA MA053158A patent/MA53158A/fr unknown
- 2019-07-19 EP EP19742045.8A patent/EP3823979B8/fr active Active
- 2019-07-19 AU AU2019304526A patent/AU2019304526B2/en active Active
- 2019-07-19 US US17/261,501 patent/US12276665B2/en active Active
- 2019-07-19 ES ES19742045T patent/ES3005559T3/es active Active
- 2019-07-19 WO PCT/EP2019/069562 patent/WO2020016433A1/fr not_active Ceased
- 2019-07-19 CA CA3106833A patent/CA3106833A1/fr active Pending
-
2024
- 2024-08-30 AU AU2024216501A patent/AU2024216501A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019304526A1 (en) | 2020-12-24 |
| US20210396761A1 (en) | 2021-12-23 |
| AU2019304526B2 (en) | 2024-09-19 |
| CA3106833A1 (fr) | 2020-01-23 |
| US12276665B2 (en) | 2025-04-15 |
| EP3823979C0 (fr) | 2024-12-18 |
| EP3823979B8 (fr) | 2025-02-26 |
| AU2024216501A1 (en) | 2024-09-19 |
| EP3823979A1 (fr) | 2021-05-26 |
| EP3823979B1 (fr) | 2024-12-18 |
| ES3005559T3 (en) | 2025-03-14 |
| WO2020016433A1 (fr) | 2020-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3443323A4 (fr) | Trieur de gouttelettes fermé et procédés d'utilisation associés | |
| EP3924373A4 (fr) | Compositions et procédés d'identification de lymphocytes t spécifiques à l'antigène | |
| EP3697297A4 (fr) | Systèmes et procédés d'identification de structures biologiques associées à des signaux de source neuromusculaire | |
| EP3622443A4 (fr) | Systèmes et procédés d'identification électronique d'espèces végétales | |
| EP3408640A4 (fr) | Procédés et appareil permettant d'identifier un récipient d'échantillon à partir de plusieurs vues latérales | |
| EP3752166A4 (fr) | Agents de liaison trialcyne et procédés d'utilisation | |
| EP3610269A4 (fr) | Procédés et appareil pour déterminer le nombre de marqueurs pendant une caractérisation d'échantillon | |
| EP3408646A4 (fr) | Procédés et appareil de caractérisation d'un récipient d'échantillon et d'un échantillon | |
| MA46200A (fr) | Procédés d'utilisation d'un anticorps bispécifique qui reconnaît le facteur de coagulation ix et/ou le facteur de coagulation ix activé et le facteur de coagulation x et/ou le facteur de coagulation x activé | |
| EP3709595A4 (fr) | Procédé et dispositif d'identification de route sécurisée | |
| MA56121A (fr) | Procédés d'identification d'attributs de protéines thérapeutiques | |
| EP3488018A4 (fr) | Procédés et compositions pour l'identification de protéines | |
| EP3484488A4 (fr) | Molécules de liaison à l'antigène et procédés d'utilisation associés | |
| EP3472358A4 (fr) | Procédés et système d'analyse épigénétique | |
| EP3487998A4 (fr) | Compositions et procédés d'identification de cibles polypeptidiques de liaison à l'arn | |
| EP3772935A4 (fr) | Système de refroidissement ultra-rapide amélioré et procédés d'utilisation | |
| EP3856905A4 (fr) | Procédés et compositions permettant d'augmenter l'expression de protéines et/ou de traiter un trouble d'haplo-insuffisance | |
| EP3631504C0 (fr) | Appareil et procédés d'imagerie radar à synthèse d'ouverture | |
| EP3448274A4 (fr) | Dispositif de guidage et procédés d'utilisation correspondants | |
| EP3796599A4 (fr) | Dispositif d'évaluation et procédé d'évaluation | |
| EP3714397A4 (fr) | Procédé et système d'identification de l'authenticité d'un d'objet | |
| EP3440595A4 (fr) | Systèmes et procédés d'identification de déchets | |
| EP3930618A4 (fr) | Dispositif et procédés de vérification d'identité | |
| EP3958727A4 (fr) | Procédés d'analyse spatiale de protéines et kits associés | |
| EP4081939A4 (fr) | Procédé d'identification de l'authenticité d'un d'objet |